Stock FUSN FUSN PHAR
Add to a list
To use this feature you must be a member
Log inSign up

News Chart FUSN PHAR

Equities

FUSN

CA36118A1003

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-14 pm EDT 		5-day change 1st Jan Change
21.43 USD 0.00% Intraday chart for FUSN PHAR +0.14% +123.00%
May. 09 Fusion Pharmaceuticals Inc. Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer CI
May. 07 Fusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
d38b396891237440.zwTZTnebkEUL4e9TGpeJcULB6PjgZavAkhGtSRw3p-0.mk-aISD0wzNd1NwBLNjxPxKKsKfYLu-u2mLnAn97392fMK8LDsLEKj6-vg~333eedbe0ddc6d835baa7b3f34699e46
  1. Stock Market
  2. Equities
  3. FUSN Stock
  4. Charts FUSN PHAR
  5. News Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW